227 related articles for article (PubMed ID: 29291438)
41. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.
Heinrich T; Böttcher H; Gericke R; Bartoszyk GD; Anzali S; Seyfried CA; Greiner HE; Van Amsterdam C
J Med Chem; 2004 Sep; 47(19):4684-92. PubMed ID: 15341484
[TBL] [Abstract][Full Text] [Related]
43. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
[TBL] [Abstract][Full Text] [Related]
44. 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors.
Bromidge SM; Bertani B; Borriello M; Faedo S; Gordon LJ; Granci E; Hill M; Marshall HR; Stasi LP; Zucchelli V; Merlo G; Vesentini A; Watson JM; Zonzini L
Bioorg Med Chem Lett; 2008 Oct; 18(20):5653-6. PubMed ID: 18799312
[TBL] [Abstract][Full Text] [Related]
45. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
46. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
47. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.
Herold F; Chodkowski A; Izbicki Ł; Król M; Kleps J; Turło J; Nowak G; Stachowicz K; Dybała M; Siwek A
Eur J Med Chem; 2009 Apr; 44(4):1710-7. PubMed ID: 18995929
[TBL] [Abstract][Full Text] [Related]
48. In the search for a lead structure among series of potent and selective hydantoin 5-HT
Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Sobiło A; Olejarz A; Kucwaj-Brysz K; Satała G; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Chem Biol Drug Des; 2017 Dec; 90(6):1295-1306. PubMed ID: 28886235
[TBL] [Abstract][Full Text] [Related]
49. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523.
Tottori K; Miwa T; Uwahodo Y; Yamada S; Nakai M; Oshiro Y; Kikuchi T; Altar CA
Neuropharmacology; 2001 Dec; 41(8):976-88. PubMed ID: 11747902
[TBL] [Abstract][Full Text] [Related]
50. Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT
Chłoń-Rzepa G; Zagórska A; Żmudzki P; Bucki A; Kołaczkowski M; Partyka A; Wesołowska A; Kazek G; Głuch-Lutwin M; Siwek A; Starowicz G; Pawłowski M
Arch Pharm (Weinheim); 2016 Dec; 349(12):889-903. PubMed ID: 27869315
[TBL] [Abstract][Full Text] [Related]
51. HBK-14 and HBK-15, triple 5-HT
Pytka K; Socała K; Rapacz A; Nieoczym D; Pieróg M; Gryboś A; Siwek A; Waszkielewicz A; Wlaź P
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):378-385. PubMed ID: 28729118
[TBL] [Abstract][Full Text] [Related]
52. [CROSS-TALK BETWEEN 5-HT1A AND 5-HT7 RECEPTORS: ROLE IN THE AUTOREGULATION OF THE BRAIN SEROTONIN SYSTEM AND IN MECHANISM OF ANTIDEPRESSANTS ACTION].
Popova NK; Ponimaskin EG; Naumenko VS
Ross Fiziol Zh Im I M Sechenova; 2015 Nov; 101(11):1270-8. PubMed ID: 26995955
[TBL] [Abstract][Full Text] [Related]
53. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
[TBL] [Abstract][Full Text] [Related]
54. Recent Developments on Future Antidepressant-related Serotonin Receptors.
Amidfar M; Kim YK
Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
[TBL] [Abstract][Full Text] [Related]
55. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C
Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991
[TBL] [Abstract][Full Text] [Related]
56. [Design, synthesis and bioactivity of aryl piperazine benzo[b][1,4]oxazine derivatives].
Zheng YY; Xie P; Zhang J; Li JQ; Guo L; Yu LP; Zhou B
Yao Xue Xue Bao; 2012 Jun; 47(6):755-63. PubMed ID: 22919723
[TBL] [Abstract][Full Text] [Related]
57. Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT
Zhang LM; Wang XY; Zhao N; Wang YL; Hu XX; Ran YH; Liu YQ; Zhang YZ; Yang RF; Li YF
Br J Pharmacol; 2017 May; 174(9):769-780. PubMed ID: 27882537
[TBL] [Abstract][Full Text] [Related]
58. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
59. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system.
Pańczyk K; Pytka K; Jakubczyk M; Rapacz A; Sałat K; Furgała A; Siwek A; Głuch-Lutwin M; Gryboś A; Słoczyńska K; Pękala E; Żmudzki P; Bucki A; Kołaczkowski M; Żelaszczyk D; Marona H; Waszkielewicz AM
Bioorg Med Chem Lett; 2018 Jun; 28(11):2039-2049. PubMed ID: 29730027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
